肥大型心筋症の表現型にわたる遺伝子検査
Aakash Bavishi1, Kutaiba Nazif2, Matthew W Martinez2
1University of Illinois Chicago, Chicago, Illinois, USA.
JACC. Case reports
|January 30, 2026
まとめ
肥大型心筋症(HCM)は、家族内での同一の遺伝子突然変異にもかかわらず、多様な臨床転帰を示す。これは、HCM患者における遺伝子検査と個別化されたリスク評価の必要性を強調するものである。
背景:
- 肥大型心筋症(HCM)は、浸透率と表現力にばらつきがある遺伝性疾患である。
- 同一の変異を有するHCM患者における臨床像は、無症候性から突然死まで多岐にわたる。
- HCMの表現型に対する遺伝的影響を理解することは、患者管理にとって極めて重要である。
結論:
- 同一のHCM変異は、家族内で同様の臨床転帰を保証するものではない。
- 遺伝子検査は、HCMの同定とリスク層別化の情報提供に不可欠である。
- 内表現型モデルは、純粋な単一遺伝子モデルよりもHCMの複雑さを捉えることができるかもしれない。
関連する概念動画
Cardiomyopathy III: Hypertrophic Cardiomyopathy
486
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
486
Cardiomyopathy II: Dilated Cardiomyopathy
563
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
563
Cardiomyopathy IV: Restrictive Cardiomyopathy
532
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
532
Cardiomyopathy V: Interprofessional Care
442
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
442
Cardiomyopathy I: Introduction and Classification
603
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
603
Cardiomyopathy VI: Nursing Management
354
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
354


